Clinical Trials in India: recent developments

GMP News
25 October 2007
 

Clinical Trials in India: recent developments

 
There have been promising developments to run clinical trials in India. To speed up the time to obtain permission to run a clinical trial in India, new trial applications are divided into categories:

  • Category A: There is already an approved protocol in one out of several countries on an approved list. The goal is to approve category A trials in between 2 and 4 weeks.
  • Category B: All other trials are placed in this category (approval time 6 - 8 weeks).

The quality of the trials performed in India shall be improved by inspections of the clinical sites, CROs and the pharmaceutical companies involved.

As a result of theses developments, more and more phase 2 and 3 studies are conducted in India and the respective local CROs expand their activities and offer services like management of the trial and the data.

Author:
Wolfgang Schmitt
On behalf of the European Compliance Academy (ECA)
 

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK